- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01975792
Fetal Thymus Involution as a Predictor of Adverse Neonatal Outcomes (TIPS)
March 28, 2017 updated by: University of Pennsylvania
Fetal Thymus Involution as a Predictor of Adverse Neonatal Outcome in Women at High Risk for Preterm Delivery
The thymus gland is a specialized organ in the chest that plays a central role in the adaptive immune system throughout development until puberty.
In response to stress, the fetal thymus gland may shrink, or involute.
The investigators propose a prospective cohort study that will enroll pregnant women admitted to labor and delivery for the management of preterm labor and/or preterm premature rupture of membranes from 28-36 weeks gestation.
Based on sonographic thymus measurements, the investigators will develop a clinical prediction tool to identify babies who are at increased risk for adverse neonatal outcomes.
A reliable non-invasive predictor of adverse neonatal outcome using thymic ultrasound measurements has the potential to affect clinical management, improve outcomes for premature babies, and direct further research efforts.
Study Overview
Status
Completed
Study Type
Observational
Enrollment (Actual)
125
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19106
- Hospital of the University of Pennsylvania
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Pregnant patients with singleton pregnancies admitted to labor and delivery at the Hospital of the University of Pennsylvania between 28-36 weeks gestation for the management of spontaneous preterm labor (defined as uterine contractions and documented cervical change) and/or preterm premature rupture of membranes.
Description
Inclusion Criteria:
- Singleton pregnancy between 28-36 weeks gestation
- Active spontaneous preterm labor symptoms (contractions, cervical dilatation and/or PPROM)
Exclusion Criteria:
- Non-singleton pregnancies
- Gestational hypertension/preeclampsia
- Major fetal anomalies
- Known fetal aneuploidy
- Intrauterine Fetal Demise
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Preterm Admits
Women who are admitted for preterm labor observation and management
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Respiratory Distress
Time Frame: Date of delivery up to 1 year
|
Neonatal respiratory compromise defined as respiratory distress requiring any CPAP (continuous positive airway pressure) and or ventilator therapy.
|
Date of delivery up to 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Nadav Schwartz, MD, University of Pennsylvania
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2013
Primary Completion (Actual)
April 1, 2014
Study Completion (Actual)
April 1, 2014
Study Registration Dates
First Submitted
September 4, 2013
First Submitted That Met QC Criteria
October 28, 2013
First Posted (Estimate)
November 5, 2013
Study Record Updates
Last Update Posted (Actual)
March 30, 2017
Last Update Submitted That Met QC Criteria
March 28, 2017
Last Verified
March 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 817255
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Women Admitted to Labor and Delivery for the Management of Preterm Labor and/or Preterm Premature Rupture of Membranes (PPROM)
-
Seoul National University HospitalCompletedPreterm Labor | Preterm Premature Rupture of Membrane (PPROM)Korea, Republic of
-
Western Galilee Hospital-NahariyaNot yet recruitingPreterm Labor With Preterm Delivery | Premature Rupture of Membranes Prolonged
-
Guy's and St Thomas' NHS Foundation TrustKing's College London; University College, LondonRecruitingPreterm Birth | Preterm Premature Rupture of Membrane | Preterm Spontaneous Labor With Preterm DeliveryUnited Kingdom
-
Ain Shams Maternity HospitalCompletedManagement of Preterm Prelabor Rupture of MembranesEgypt
-
Woman'sRecruitingPreterm Birth | Preterm Labor | Rupture of Membranes; Premature | Rupture of Membranes; Delayed Delivery (Following Spontaneous Rupture) | Rupture of Membranes; Premature, Affecting Fetus | Preterm PROM (Pregnancy)United States
-
Chelsea and Westminster NHS Foundation TrustSPD Development Company Limited; Borne CharityRecruitingPreterm Birth | Preterm Labor | Preterm Birth Complication | Preterm Premature Rupture of Membrane | Preterm PregnancyUnited Kingdom
-
Chelsea and Westminster NHS Foundation TrustNot yet recruitingThreatened Preterm Labor | Preterm Rupture of Membranes
-
Mark SantillanAmniSure International LLCTerminatedPreterm Birth | Preterm LaborUnited States
-
Thomas Jefferson UniversityUnknownPreterm Premature Rupture of MembranesUnited States
-
Erzincan Military HospitalCompletedPreterm Premature Rupture of MembranesTurkey